Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing Pharmaceutical TechnologyWhen Eli Lilly's Lebanon campus is complete, it will manufacture several of the pharma's APIs and genetic medicines to serve US patients.Read full story pharminent May 7, 2026 (Last updated: May 8, 2026) Pharmaceutical Technology When Eli Lilly’s Lebanon campus is complete, it will manufacture several of the pharma’s APIs and genetic medicines to serve US patients. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Daiichi Sankyo and Waiv partner for ADC biomarkersNext: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies Related Stories Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026 Manufacturing GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy pharminent July 29, 2026 Manufacturing GSK to quit Stevenage for new R&D site in Cambridge pharminent July 28, 2026
